NO20032189D0 - Behandling av antidepresjonsmiddel-indusert seksuell dysfunksjon med apomorfin - Google Patents

Behandling av antidepresjonsmiddel-indusert seksuell dysfunksjon med apomorfin

Info

Publication number
NO20032189D0
NO20032189D0 NO20032189A NO20032189A NO20032189D0 NO 20032189 D0 NO20032189 D0 NO 20032189D0 NO 20032189 A NO20032189 A NO 20032189A NO 20032189 A NO20032189 A NO 20032189A NO 20032189 D0 NO20032189 D0 NO 20032189D0
Authority
NO
Norway
Prior art keywords
apomorphine
antidepressant
treatment
sexual dysfunction
induced sexual
Prior art date
Application number
NO20032189A
Other languages
English (en)
Other versions
NO20032189L (no
Inventor
Renee J Perdok
Dustin D Ruff
Original Assignee
Tap Pharmaceutical Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tap Pharmaceutical Prod Inc filed Critical Tap Pharmaceutical Prod Inc
Publication of NO20032189D0 publication Critical patent/NO20032189D0/no
Publication of NO20032189L publication Critical patent/NO20032189L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
NO20032189A 2000-11-15 2003-05-14 Behandling av antidepresjonsmiddel-indusert seksuell dysfunksjon med apomorfin NO20032189L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24903100P 2000-11-15 2000-11-15
PCT/US2001/043933 WO2002039879A2 (en) 2000-11-15 2001-11-14 Treatment of anti-depression drug-induced sexual dysfunction with apomorphine

Publications (2)

Publication Number Publication Date
NO20032189D0 true NO20032189D0 (no) 2003-05-14
NO20032189L NO20032189L (no) 2003-07-08

Family

ID=22941748

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20032189A NO20032189L (no) 2000-11-15 2003-05-14 Behandling av antidepresjonsmiddel-indusert seksuell dysfunksjon med apomorfin

Country Status (18)

Country Link
US (1) US6528521B2 (no)
EP (1) EP1341536A4 (no)
JP (1) JP2004513899A (no)
KR (1) KR20030077538A (no)
CN (1) CN1486183A (no)
AU (1) AU2002235129A1 (no)
BG (1) BG107874A (no)
BR (1) BR0111982A (no)
CA (1) CA2429047A1 (no)
CZ (1) CZ20031540A3 (no)
HU (1) HUP0302436A3 (no)
IL (1) IL155667A0 (no)
MX (1) MXPA03004288A (no)
NO (1) NO20032189L (no)
PL (1) PL361875A1 (no)
SK (1) SK7422003A3 (no)
WO (1) WO2002039879A2 (no)
ZA (1) ZA200303471B (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6787532B2 (en) * 2000-08-05 2004-09-07 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivatives
CA2522231A1 (en) * 2003-04-14 2004-10-21 Vectura Ltd Pharmaceutical compositions comprising apomorphine for pulmonary inhalation
US20040204439A1 (en) * 2003-04-14 2004-10-14 Staniforth John Nicholas Composition, device, and method for treating sexual dysfunction via inhalation
WO2005023767A2 (en) 2003-09-10 2005-03-17 Brentwood Equities Ltd. Diastereomers of 4-aryloxy-3-hydroxypiperidines
GB0425758D0 (en) 2004-11-23 2004-12-22 Vectura Ltd Preparation of pharmaceutical compositions
GB0721394D0 (en) * 2007-10-31 2007-12-12 Vectura Group Plc Compositions for trating parkinson's disease
WO2012083269A1 (en) 2010-12-16 2012-06-21 Cynapsus Therapeutics, Inc. Sublingual films
WO2014105655A1 (en) 2012-12-24 2014-07-03 Neurogastrx, Inc. Methods for treating gi tract disorders
CA3019769C (en) * 2015-04-21 2021-10-12 Sunovion Pharmaceuticals Inc. Methods of treating parkinson's disease by administration of apomorphine to an oral mucosa
WO2017168174A1 (en) 2016-04-02 2017-10-05 N4 Pharma Uk Limited New pharmaceutical forms of sildenafil
US11382867B2 (en) 2018-01-18 2022-07-12 Leukos Biotech, S. L. Apomorphine-palmitic acid cocrystal solid particle crystalline form
US11717495B2 (en) * 2020-03-16 2023-08-08 Vella Bioscience, Inc. Use of cannabinoids in treating anti-depressant-induced female sexual dysfunction
US10836757B1 (en) 2020-04-02 2020-11-17 Neurogastrx, Inc. Polymorphic forms of metopimazine
CN115671106B (zh) * 2021-07-21 2024-03-19 广州新济药业科技有限公司 吗啡的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4521421A (en) * 1983-09-26 1985-06-04 Eli Lilly And Company Treatment of sexual dysfunction
ES2239369T3 (es) 1993-03-26 2005-09-16 Franciscus Wilhelmus Henricus Maria Merkus Composiciones farmaceuticas para administracion intranasal de dihidroergotamina.
PT758895E (pt) 1994-04-22 2000-05-31 Univ Kingston Formas de dosagem sublingual contendo apomorfina para uso no tratamento da disfuncao erectil
US5562917A (en) 1994-12-23 1996-10-08 Pentech Pharmaceuticals, Inc. Transdermal administration of apomorphine
US5888534A (en) * 1995-06-13 1999-03-30 Pentech Pharmaceuticals, Inc. Controlled release of drugs delivered by sublingual or buccal administration
DK0914097T3 (da) 1996-03-12 2002-04-29 Alza Corp Sammensætning og doseringsform omfattende opioid antagonist
US5897864A (en) 1996-05-23 1999-04-27 Cohen; Alan J. Method for treating sexual dysfunction disorders with compositions containing ginkgo biloba
AU731349B2 (en) * 1996-12-02 2001-03-29 Merck Sharp & Dohme Limited Use of NK-1 receptor antagonists for treating sexual dysfunctions
US5945117A (en) 1998-01-30 1999-08-31 Pentech Pharmaceuticals, Inc. Treatment of female sexual dysfunction
US6399826B1 (en) * 1999-08-11 2002-06-04 Sepracor Inc. Salts of sibutramine metabolites, methods of making sibutramine metabolites and intermediates useful in the same, and methods of treating pain

Also Published As

Publication number Publication date
CZ20031540A3 (cs) 2004-05-12
BG107874A (bg) 2004-01-30
US20020115683A1 (en) 2002-08-22
MXPA03004288A (es) 2004-09-10
IL155667A0 (en) 2003-11-23
EP1341536A2 (en) 2003-09-10
KR20030077538A (ko) 2003-10-01
US6528521B2 (en) 2003-03-04
BR0111982A (pt) 2003-10-28
JP2004513899A (ja) 2004-05-13
EP1341536A4 (en) 2007-08-01
CN1486183A (zh) 2004-03-31
ZA200303471B (en) 2004-08-06
SK7422003A3 (en) 2004-01-08
PL361875A1 (en) 2004-10-04
HUP0302436A2 (hu) 2003-11-28
WO2002039879A2 (en) 2002-05-23
AU2002235129A1 (en) 2002-05-27
NO20032189L (no) 2003-07-08
WO2002039879A3 (en) 2002-07-25
HUP0302436A3 (en) 2004-10-28
CA2429047A1 (en) 2002-05-23

Similar Documents

Publication Publication Date Title
NO20033508D0 (no) Medikament med hurtig virkningsbegynnelse for behandling av seksuell dysfunksjon
NO20003845L (no) Behandling av kvinnelig seksuell dysfunksjon
PL377729A1 (pl) Sposób leczenia dysfunkcji seksualnej
NO20024442D0 (no) Behandling av seksuell dysfunksjon med apomorfin
IL153492A0 (en) Treatment of male sexual dysfunction
NO20032189L (no) Behandling av antidepresjonsmiddel-indusert seksuell dysfunksjon med apomorfin
GB0225908D0 (en) Treatment of female sexual dysfunction
AU2002238106A1 (en) Melanocortin metallopeptides for treatment of sexual dysfunction
NO20030978D0 (no) Behandling av diuresedysfunksjon
IL162154A0 (en) Prostagandin composition for the treatment of erectile dysfunction
IL162455A0 (en) Compounds for the treatment of sexual dysfunction
PL362980A1 (en) Treatment of sexual dysfunction
DE50009813D1 (de) Kombinationpräparat zur behandlung von sexueller dysfunktion
AU2002246924A8 (en) Treatment of erectile dysfunction with rho-kinase inhibitors
IL155775A0 (en) Treatment of male sexual dysfunction
GB2386555B (en) Treatment of female sexual dysfunction
AU8906201A (en) Methods and compositions for the treatment and prevention of sexual dysfunction
IL155814A0 (en) Treatment of sexual dysfunction using bombesin antagonist
GB0011926D0 (en) Treatment of sexual dysfunction
DK1196184T3 (da) Sammensætninger til behandling af seksuel dysfunktion
GB0321308D0 (en) Treatment of sexual dysfunction
GB0318095D0 (en) Treatment of sexual dysfunction
GB0111037D0 (en) Treatment of sexual dysfunction
GB0109910D0 (en) Treatment of sexual dysfunction
GB0126904D0 (en) Treatment of sexual dysfunction